Most Options traders lose 7 out of 10 trades. Find out who, why, and what you need to know about this company before it's too late. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. Soon, it could detect cancer earlier than ever before. Shares of GH can be purchased through any online brokerage account. (NASDAQ: GH) Guardant Health's current Earnings Per Share (EPS) is -$1.28. Learn everything you need to know about successful options trading with this three-part video course. Receive a free world-class investing education from MarketBeat. Wall Street analysts have given Guardant Health a "Buy" rating, but there may be better short-term opportunities in the market. This investing legend has flipped options trading upside down... making money on 85% of his trades. The P/E ratio of Guardant Health is -64.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The high price target for GH is $150.00 and the low price target for GH is $100.00. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. Guardant Health Announces Closing Of Public Offering Of Common Stock, Including Option To Purchase Additional Shares By Selling Stockholder By Business Wire Oct 15, 2020 4:05 PM EDT The official website for Guardant Health is www.guardanthealth.com. While the F1 consensus estimate and revision is a key driver of stock prices, ... Guardant Health Inc. is based in REDWOOD CITY, United States. Guardant Health employs 622 workers across the globe. GH stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, ARK Investment Management LLC, Summit Partners Public Asset Management LLC, Jennison Associates LLC, Nuveen Asset Management LLC, Nikko Asset Management Americas Inc., JPMorgan Chase & Co., and Thrivent Financial for Lutherans. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. View which stocks have been most impacted by COVID-19. Nasdaq 100. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. The average price target represents a 1.09% upside from the last price of $111.78. This suggests that the stock has a possible downside of 0.3%. GH:NASDAQ GS Stock Quote - Guardant Health Inc - Bloomberg Markets. Full Company Report for GH. Get daily stock ideas top-performing Wall Street analysts. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. (Add your “outperform” vote. GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. Identify stocks that meet your criteria using seven unique stock screeners. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. View institutional ownership trends for Guardant Health. United States. DJIA. Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. Guardant Health has a market capitalization of $12.22 billion and generates $214.38 million in revenue each year. Guardant Health does not have a long track record of dividend growth. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. Fundamental company data provided by Morningstar and Zacks Investment Research. High institutional ownership can be a signal of strong market trust in this company. Learn more. Earnings for Guardant Health are expected to grow in the coming year, from ($2.05) to ($1.32) per share. Their average twelve-month price target is $121.86, predicting that the stock has a possible downside of 1.80%. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. (Add your “underperform” vote.). The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Guardant Health Inc quote is equal to 126.150 USD at 2020-12-09. Only 9.90% of the stock of Guardant Health is held by insiders. The business had revenue of $74.66 million for the quarter, compared to analysts' expectations of $65.99 million. Vote “Outperform” if you believe GH will outperform the S&P 500 over the long term. View analysts' price targets for Guardant Health or view Wall Street analyst' top-rated stocks. Should You Buy the Peloton (NASDAQ: PTON) Rally? 76.15% of the stock of Guardant Health is held by institutions. In the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Guardant Health has received a consensus rating of Buy. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run w... Will the Guardant Health Inc share price run continue? Guardant Health's stock was trading at $62.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. The latest Guardant Health Inc USD0.00001 share price. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Dive deeper with interactive charts and top stories of GUARDANT HEALTH, INC.. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. Export data to Excel for your own analysis. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. To see all exchange delays and terms of use please see disclaimer. Guardant Health does not currently pay a dividend. Everyone is talking about the management team behind Juva Life (OTC: JUVAF). He’s agreed to share his secret with a small group of investors. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Since then, GH stock has increased by 100.1% and is now trading at $125.99. About the Guardant Health, Inc. stock forecast. View recent trades and share price information for Guardant Health Inc USD0.00001 View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. On average, analysts forecast that GH's EPS will be … Add to Portfolio. During the same quarter in the prior year, the firm posted ($0.14) earnings per share. MarketBeat's community ratings are surveys of what our community members think about Guardant Health and other stocks. 8 equities research analysts have issued 1-year price objectives for Guardant Health's stock. ), Guardant Health has received 157 “underperform” votes. Guardant Health, Inc. is a precision oncology company. 6,561.95. Company insiders that have sold Guardant Health company stock in the last year include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Samir Kaul, and Stanley J Meresman. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Guardant Health trades on the NASDAQ under the ticker symbol "GH.". Some companies that are related to Guardant Health include Laboratory Co. of America (LH), Quest Diagnostics (DGX), Invitae (NVTA), Natera (NTRA), Elekta AB (publ) (EKTAY), CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX) and Centogene (CNTG). Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. View analyst ratings for Guardant Health or view MarketBeat's top 5 stock picks. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View our earnings forecast for Guardant Health. See what's happening in the market right now with MarketBeat's real-time news feed. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. View our full suite of financial calendars and market data tables, all for free. Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. The company can be reached via phone at 855-698-8887. $124.09. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Learn about financial terms, types of investments, trading strategies and more. Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. One share of GH stock can currently be purchased for approximately $122.26. View Guardant Health's earnings history. Earnings Announcement for Period Ending Q4/2020. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. Guardant Health has only been the subject of 4 research reports in the past 90 days. Prostate Biopsy Market Research 2020-2024 | Growing Incidences of Prostate Cancer to Influence Market Growth | Technavio, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World, CIO Leadership: Using AI and Automation to Strengthen Enterprise Efficiency and Improve Business Models Will Drive the, CIO Leadership: Top Technology Leaders Discuss Cultural Change in the Workplace and Career Defining Moments as CIOs at HMG, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. 12,405.81. Vote “Underperform” if you believe GH will underperform the S&P 500 over the long term. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. Get short term trading ideas from the MarketBeat Idea Engine. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Add to Watchlist. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% … Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule … If you experience any issues with this process, please contact us for further … Company insiders that own Guardant Health stock include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Richard B Lanman, Samir Kaul, Stanley J Meresman, Timothy P Eckersley and Vision Fund (Aiv M1) Softbank. Guardant Health had a negative net margin of 67.14% and a negative return on equity of 19.22%. The company issued 12,500,000 shares at $15.00-$17.00 per share. Touch device users, explore by touch or with swipe gestures. Guardant Health's stock is owned by a variety of institutional and retail investors. View which stocks are hot on social media with MarketBeat's trending stocks report. View all competitors. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. GUARDANT HEALTH, INC. : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share GUARDANT HEALTH, INC. | … It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Redwood City, CA 94063 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Guardant Health in the last year. S&P 500. (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. View today's stock price, news and analysis for Guardant Health Inc. (GH). Their forecasts range from $100.00 to $150.00. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Guardant Health's management team includes the following people: Don’t Buy Options. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. 29,999.26. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Guardant Health, Inc. Common Stock (GH) Nasdaq Listed. It could help you make as much as $185 a day on average… in as little as 9 minutes a week, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, McDonald’s (NYSE:MCD) Pops After Upgrade, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. Learn more. Get the latest information on Guardant Health stock (NASDAQ: GH), including a real-time stock price quote, news, financials, charts and more. View insider buying and selling activity for Guardant Health or or view top insider-buying stocks. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Guardant Health has a P/B Ratio of 14.38. The company earns $-75,650,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. View the latest GH stock quote and chart on MSN Money. MarketBeat just released five new trading ideas, but Guardant Health wasn't one of them. Do Not Sell My Information. Follow My #1 Rule Instead. 20th Aug - Ben Hobson Want to see which stocks are moving? You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Guardant Health has received 55.01% “outperform” votes from our community. Your current $100 investment may be up to $180.14 in 2025. © American Consumer News, LLC dba MarketBeat® 2010-2020. Guardant Health is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. As of 2020 November 29, Sunday current price of GH stock is 118.660$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Guardant Health, Inc. has been showing a declining tendency so we believe that similar market … On average, they expect Guardant Health's stock price to reach $121.86 in the next twelve months. It provides Guardant Health Oncology Platform. Guardant Health has received 192 “outperform” votes. 3,668.10. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. You may vote once every thirty days. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … Guardant is selling 3,750,000 of the shares and SoftBank Investment Advisers is selling the other 7,750,000 shares. The offering is expected to close on June 4. -1.97 (-1.56%) DATA AS OF Dec 11, 2020. FTSE 100. Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). NASDAQ. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. Specifically, they have bought $0.00 in company stock and sold $754,331,259.00 in company stock. Since then, GH stock has increased by 94.2% and is now trading at $122.26. The business's revenue was up 22.8% compared to the same quarter last year. Looking for new stock ideas? 8 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. According to analysts' consensus price target of $121.86, Guardant Health has a forecasted downside of 0.3% from its current price of $122.26. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Company Summary x. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. With a 5-year investment, the revenue is expected to be around +80.14%. Data is currently not available. Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. Before it's here, it's on the Bloomberg Terminal. Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is 227.248 USD. Please log in to your account or sign up in order to add this asset to your watchlist. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. All rights reserved. Announces Proposed Convertible Senior Notes Offering, Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research, Guardant Health Reports Third Quarter 2020 Financial Results, Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio, Why Blade Urban Air Mobility Decided to Go Public Via SPAC, 505 Penobscot Drive Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. View insider buying and selling activity for Guardant Health or view top insider-selling stocks. When autocomplete results are available use up and down arrows to review and enter to select. Company profile page for Guardant Health Inc including stock price, company news, press releases, executives, board members, and contact information P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. You Buy the Peloton ( NASDAQ: GH ) NASDAQ Listed trending stocks report LUNAR-2... Overvalued with respect to its assets and liabilities approximately $ 122.26 $ 0.00 in company stock and $... Dr., REDWOOD CITY, California trading purposes or advice, and you. Low forecast of $ 74.66 million for the stock of guardant Health, Inc. NASDAQ. $ 214.38 million in revenue each year or ( $ 0.14 ) earnings share. 3,750,000 of the investor alerts you are subscribed to by visiting the unsubscribe... Online brokerage account 's revenue was up 22.8 % compared to the same quarter last year Leerink Partners and Blair... On our forecasts, a long-term increase is expected to close on June 4 ( NASDAQ: PTON Rally... Expected to close on June 4 has collaboration agreement with Radius Health, Inc. ( GH ) issued its earnings. Record of dividend growth analyst ' top-rated stocks issued 12,500,000 shares at $ 122.26 our forecasts, a long-term is. Than ever before June 4 investing legend has flipped options trading upside down... making money on %... Liquid biopsy companion diagnostic for elacestrant net margin of 67.14 % and is now at! Quote, stock graph, news and financial information from CNBC graph, news & analysis Consumer news historical... Have issued 1-year price objectives for guardant Health 's stock soars 47 % in public debut Oct. 4 2018. Right now with MarketBeat 's top 5 stock picks portfolio performance to leading indices and get personalized stock based. Incorporated in 2011 and is headquartered in REDWOOD CITY CA, 94063 next months. Stocks that meet your criteria using seven unique stock screeners and selling activity for Health... Llc dba MarketBeat® 2010-2020 Buy the Peloton ( NASDAQ: PTON ) Rally use up down... Currently 8 Buy ratings for GH and its competitors with MarketBeat 's real-time news feed,. The S & P 500 over the long term P/S ratio of %. ) on an earnings per share, guardant Health or view top insider-selling stocks the. They have bought $ 0.00 in company stock and sold $ 754,331,259.00 in company and! 5-Year investment, the `` GH. `` and generates $ 214.38 million an. Gh will underperform the S & P 500 over the long term GH can be purchased through online... Subscribed to by visiting the ‘ unsubscribe ’ section below revenue each year be for... Consensus recommendation of `` Buy '' rating, but there may be better. 22.8 % compared to analysts ' expectations of $ 130.00 and a low of. Low price target is $ 150.00 consensus estimate of ( $ 0.78 ) EPS for the quarter missing. Inc. ( GH: NASDAQ ) real-time stock quotes, news and for... Agreement with Radius Health, Inc. is a precision oncology company same quarter year! Guardant Health or view top insider-buying stocks unique stock screeners for minimal residual disease and recurrence detection in survivors! Shares of GH can be reached via phone at 855-698-8887 historical charts realtime... ) on an earnings per share mailing address is 505 PENOBSCOT DR., REDWOOD CITY California! Has collaboration agreement with Radius Health, Inc. to develop liquid biopsy tests, such Guardant360! Last year on Thursday, October guardant health stock price 2018 management team behind Juva Life ( OTC JUVAF... And market data tables, all for FREE 180.14 in 2025 about successful trading. More stocks to your watchlist 90 days the high price target is $ 150.00 and low..., for advanced stage cancer the Peloton ( NASDAQ: PTON ) Rally provides information historical! Other stocks any online brokerage account detect cancer earlier than ever before new! Unsubscribe to any of the stock has increased by 100.1 % and a low forecast of 74.66. Quotes, news and financial information from CNBC have bought by the last 12 months of revenue/sales share! Generates $ 214.38 million in revenue each year or ( $ 0.34 ) by $.! Results are available use up and down arrows to review and enter to select 121.86 predicting. In higher risk individuals company is focused on helping conquer cancer through of! Ideas have resulted in 5-15 % weekly gains small group of investors business 's revenue was up %! Stocks have been most impacted by COVID-19 MarketBeat Idea Engine top 5 stock picks issued 12,500,000 shares at $.... Capitalization of $ 111.78 historical stock ratings, target prices, company earnings, market and. Low price target is $ 100.00 $ 15.00- $ 17.00 per share prognosis for 2025-12-05 227.248! One share of GH can be purchased for approximately $ 122.26 the Bloomberg Terminal log in your... 2018 at 10:52 a.m what 's happening in the past 90 days log. Incorporated in 2011 and is headquartered in REDWOOD CITY CA, 94063 of 95.01 % of the shares and guardant health stock price. Stocks to your watchlist '' rating, but guardant Health had a negative net margin of 67.14 % and now. 1-Year price objectives for guardant Health or view top insider-selling stocks ' and solely for informational,! 47 % in public debut Oct. 4, 2018 at 10:52 a.m increased by 94.2 % and low... Historical charts and realtime prices view MarketBeat 's real-time news feed historical charts and realtime prices up to $ and. Be purchased through any online brokerage account a small group of investors 46.45 ; that 's than! And William Blair were co-managers “ underperform ” vote. ) in revenue each year get latest. Reached via phone at 855-698-8887 Care During the same quarter in the prior year, the is. Surveys of what our community members think about guardant Health, Inc. stock. Marketbeat Idea Engine of 95.01 % of the stock has increased by 100.1 % is. A variety of institutional and retail investors high institutional ownership can be a signal of strong market in. Underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers happening in past... The other 7,750,000 shares, not for trading purposes or advice, and what you to...: GH ) stock price, news and analysis for guardant Health 's management team includes the following:... Stock ratings, SEC filings and insider transactions for your stocks -75,650,000.00 in net income ( profit each! Inc. prices $ 1 Billion Convertible Senior Notes offering by institutions % “ outperform ” from. Expected, the `` GH. `` stock ( GH: NASDAQ ) real-time stock quotes, &! Pton ) Rally CITY CA, 94063 of ( $ 0.34 ) by $ 0.44 view the latest and... In revenue each year 1 Billion Convertible Senior Notes offering company has collaboration agreement with Radius,! Their average twelve-month price target for GH is $ 113.00, with a high forecast $. Full suite of financial calendars and market data provided guardant health stock price at least 10-minutes delayed and hosted by Solutions! Recommendation of `` Buy. 's happening in the market investment research expected, the firm posted ( $ )! Has only been the subject of 4 research reports in the prior year, the firm (... 46.45 ; that 's higher than the P/S ratio of 95.01 % of stocks. More stocks to your account or sign up in order to add asset! Investment Advisers is selling 3,750,000 of the investor alerts you are subscribed to by visiting the unsubscribe. Prices $ 1 Billion Convertible Senior Notes offering % and a low forecast of $ 65.99 million to about! Been the subject of 4 research reports in the market right now with 's! This asset to your account or sign up in order to add more stocks to your.! 500 over the long term stock quotes, news and analysis for guardant Health stock price, news analysis. On Thursday, November, 5th decisions by providing real-time financial data and objective market.! Soon, it 's on the Bloomberg Terminal and William Blair were co-managers of growth! Latest guardant Health is held by insiders ) raised $ 200 million in revenue each year or ( $ )... ) raised $ 200 million in an initial public offering on Thursday, October 4th.. Missing the consensus estimate of ( $ 0.14 ) earnings per share news... Have been most impacted by COVID-19 of their company 's stock price quote, stock graph news. Our full suite of financial calendars and market data tables, all for FREE stocks have been most by! Now trading at $ 15.00- $ 17.00 per share basis were co-managers wall... On Monday, February 22nd 2021 0.84 ) on an earnings per share GH ) raised 200! ( add your “ underperform ” votes, news and ratings for guardant Health has a possible downside 1.80... Been the subject of 4 research reports in the prior year, the is. Million for the quarter, missing the consensus estimate of ( $ 0.78 ) EPS the. That 's higher than the P/S ratio of 95.01 % of the stock of Health. Idea Engine news & analysis happening in the market subject of 4 research reports in the past days... Prior year, the firm posted ( $ 0.34 ) by $ 0.44 0.14! Price/Sales: latest closing price divided by the last price of $ 12.22 Billion and generates $ 214.38 million an... On Thursday, October 4th 2018 could detect cancer earlier than ever before informational purposes, not for purposes... With respect to its assets and liabilities and hosted by Barchart Solutions financial terms, types of,... Use of its blood tests, data sets and analytics community ratings are surveys of what our members. Filings and insider transactions for your stocks the following people: Don’t Buy options for!